ANO «National Scientific Center for Pharmacovigilance» provides a full range of services for pharmacovigilance (monitoring the effectiveness and safety) of drugs, veterinary drugs, medical devices, user testing.
Our specialists have prepared more than 1,500 periodic reports (PSURs and DSURs). Experienced medical writers, peer reviewing, and continual process improvement.
Detailed and brief description of the pharmacovigilance system, standard operating procedures, and the service of providing contact persons in countries of presence.
There are scheduled inspections in accordance with the risk-based approach, as well as unplanned inspections carried out to assess suspected non-conformities or potential risks
User testing is the testing of an insert sheet to examine the readability, clarity, and accessibility of the package information leaflet by target patient groups.
Includes: preparation of drug samples for registration review, writing sections 2,4-2,7 of the registration dossier, variations to the registered documents.
— medicinal product authorization
— registration of a pharmaceutical substance as part of the authorization of a finished drug;
— registration of a substance, which is supplied for sale to several plants for further production of finished drugs
— dietary supplements authorization
This is part of a clinical trial, conducted with human participants to compare the pharmacological properties (pharmacokinetics, pharmacodynamics, toxicity, etc.) of the generic and the reference drug.
Addressing issues related to the optimization of staffing and operation of the company’s budget, as well as reducing the risks associated with resolving labor disputes.
Studies conducted to identify, characterize, or quantify safety hazards, confirm a drug’s safety profile, or evaluate the effectiveness of risk management measures
From individual counseling on individual critical processes of pharmacovigilance to building a complete system for monitoring efficacy and safety at all stages of drug research and circulation.